| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0004 |